2.18

5.31% 0.11

Goodrx Holdings Inc (GDRX)

Overview News Price History Option Chain Financials Why GDRX Down? Discussions Forecast

Goodrx Holdings Inc stock is traded at $2.18, with a volume of 3.19M. It is up +5.31% in the last 24 hours and down -1.36% over the past month. GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

Previous Close:

$2.07

Open:

$2.08

24h Volume:

3.19M

Relative Volume:

1.11

Market Cap:

$739.96M

Revenue:

$775.09M

Net Income/Loss:

$-58.68M

P/E Ratio:

-16.44

EPS:

-0.1326

Net Cash Flow:

$64.06M

1W Performance:

-11.02%

1M Performance:

-1.36%

6M Performance:

-49.07%

1Y Performance:

-53.32%

1-Day Range:

$2.08

$2.24

1-Week Range:

$1.77

$2.24

52-Week Range:

$1.77

$5.8099

Goodrx Holdings Inc Stock (GDRX) Company Profile

Name

Goodrx Holdings Inc

Sector

Healthcare (1106)

Industry

Health Information Services (49)

Phone

(855) 268-2822

Address

2701 OLYMPIC BOULEVARD, SANTA MONICA

Employee

738

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

GDRX's Discussions on Twitter

Compare GDRX vs VEEV, TEM, BTSG, HQY, WAY

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GDRX Goodrx Holdings Inc	2.18	702.63M	775.09M	-58.68M	64.06M	-0.1326
VEEV Veeva Systems Inc	188.48	30.56B	3.08B	860.33M	1.35B	5.1463
TEM Tempus Ai Inc	51.29	9.19B	1.27B	-245.03M	-245.36M	-1.4071
BTSG Brightspring Health Services Inc	41.96	7.33B	11.99B	24.18M	234.31M	0.2956
HQY Healthequity Inc	81.15	6.87B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	26.93	5.09B	906.14M	-52.62M	89.62M	-0.3621

Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-22-26	Downgrade	Jefferies	Buy → Hold
Dec-09-25	Initiated	Barclays	Underweight
Aug-11-25	Downgrade	Raymond James	Strong Buy → Outperform
Dec-04-24	Initiated	Mizuho	Neutral
Aug-09-24	Upgrade	Raymond James	Outperform → Strong Buy
May-23-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
May-16-24	Upgrade	Raymond James	Mkt Perform → Outperform
Apr-10-24	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-25-24	Upgrade	Wells Fargo	Equal Weight → Overweight
Mar-01-24	Upgrade	JP Morgan	Neutral → Overweight
Feb-26-24	Initiated	Leerink Partners	Outperform
Jan-02-24	Downgrade	BofA Securities	Buy → Underperform
Aug-10-23	Upgrade	DA Davidson	Neutral → Buy
Jul-31-23	Upgrade	TD Cowen	Market Perform → Outperform
Dec-01-22	Initiated	Citigroup	Buy
Nov-04-22	Upgrade	JP Morgan	Underweight → Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold
Aug-12-22	Initiated	DA Davidson	Neutral
Jun-10-22	Downgrade	Goldman	Buy → Neutral
Jun-06-22	Resumed	BofA Securities	Buy
Jun-01-22	Downgrade	Robert W. Baird	Outperform → Neutral
May-10-22	Downgrade	Evercore ISI	Outperform → In-line
May-10-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
May-10-22	Downgrade	Raymond James	Outperform → Mkt Perform
May-10-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
Apr-11-22	Initiated	Wells Fargo	Equal Weight
Apr-07-22	Initiated	Guggenheim	Buy
Apr-01-22	Resumed	Credit Suisse	Neutral
Mar-15-22	Upgrade	Robert W. Baird	Neutral → Outperform
Mar-01-22	Reiterated	Barclays	Overweight
Mar-01-22	Reiterated	BofA Securities	Neutral
Mar-01-22	Downgrade	Cowen	Outperform → Market Perform
Mar-01-22	Downgrade	Credit Suisse	Outperform → Neutral
Mar-01-22	Reiterated	Evercore ISI	Outperform
Mar-01-22	Reiterated	Goldman	Buy
Mar-01-22	Reiterated	JP Morgan	Underweight
Mar-01-22	Reiterated	RBC Capital Mkts	Outperform
Mar-01-22	Reiterated	SVB Leerink	Outperform
Jan-07-22	Initiated	Goldman	Buy
Dec-21-21	Initiated	Stephens	Overweight
Dec-02-21	Initiated	Jefferies	Buy
Aug-31-21	Upgrade	Barclays	Equal Weight → Overweight
Aug-13-21	Upgrade	Raymond James	Mkt Perform → Outperform
May-28-21	Initiated	Robert W. Baird	Neutral
Apr-06-21	Resumed	Evercore ISI	Outperform
Jan-25-21	Initiated	Guggenheim	Buy
Nov-19-20	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Nov-18-20	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Oct-19-20	Initiated	Barclays	Equal Weight
Oct-19-20	Initiated	BofA Securities	Neutral
Oct-19-20	Initiated	Citigroup	Buy
Oct-19-20	Initiated	Cowen	Outperform
Oct-19-20	Initiated	Credit Suisse	Outperform
Oct-19-20	Initiated	Deutsche Bank	Hold
Oct-19-20	Initiated	Goldman	Neutral
Oct-19-20	Initiated	JP Morgan	Neutral
Oct-19-20	Initiated	Morgan Stanley	Overweight
Oct-19-20	Initiated	RBC Capital Mkts	Sector Perform
Oct-19-20	Initiated	SVB Leerink	Outperform
Oct-19-20	Initiated	UBS	Buy

View All

Goodrx Holdings Inc Stock (GDRX) Latest News

Mar 04, 2026

GDRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026

GDRX: Wells Fargo Maintains Rating, Lowers Price Target by 50% | - GuruFocus

Mar 04, 2026

Wells Fargo & Company Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock Price - MarketBeat

Mar 04, 2026

Mar 03, 2026

GoodRx Holdings (GDRX) Analyst Rating Update: Citigroup Lowers P - GuruFocus

Mar 03, 2026

Citigroup Lowers GoodRx (NASDAQ:GDRX) Price Target to $3.50 - MarketBeat

Mar 03, 2026